BNC lands cancer drug formulation contract

Bio Nano Consulting (BNC) says University of London School of Pharmacy deal helped land first Ph I trial formulation services contract.

The UK firm, a nanotechnology partnering focused JV between the University of London School of Pharmacy and Imperial College London, will mange development of an orally-available formulation of a candidate cancer treatment for an undisclosed US biotech developer.

The proof-of-concept project, which will be conducted by researchers at the School of Pharmacy, follows signing of a service level agreement (SLA) with the institution and extends the scope of BNC’s trial support expertise according to CEO David Sarphie.

The SLA significantly expands our established pool of world class scientist that we manage and draw upon for specific life science projects, including cancer research​.”

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers